RPTX
USDRepare Therapeutics Inc. Common Shares
Preço em tempo real
Gráfico de preços
Métricas-chave
Métricas de mercado
Abertura
$1.820
Máximo
$1.855
Mínimo
$1.780
Volume
0.15M
Fundamentos da empresa
Capitalização de mercado
76.5M
Setor
Biotecnologia
País
Canada
Estatísticas de negociação
Volume médio
0.13M
Bolsa de valores
NMS
Moeda
USD
Faixa de 52 semanas
Notícias relacionadas
HC Wainwright & Co. Maintains Buy on Repare Therapeutics, Lowers Price Target to $3
HC Wainwright & Co. analyst Robert Burns maintains Repare Therapeutics with a Buy and lowers the price target from $5 to $3.
HC Wainwright & Co. Maintains Buy on Repare Therapeutics, Lowers Price Target to $3
HC Wainwright & Co. analyst Robert Burns maintains Repare Therapeutics with a Buy and lowers the price target from $5 to $3.
Repare Therapeutics to Present Initial Data from Phase 1 LIONS Clinical Trial at 37th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Repare Therapeutics Inc. ("Repare" or the "Company") (NASDAQ:RPTX), a clinical-stage precision oncology company, today announced it will share initial topline safety, tolerability and early efficacy data from the Phase
Ações relacionadas
Mantenha-se atualizado
Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.